Q&A: Chemoradiation With Radiotherapy Improves NSCLC Outcomes
“This technology gives us the ability to be more precise and personalized to each patient,” says Percy Lee, MD. ...
“This technology gives us the ability to be more precise and personalized to each patient,” says Percy Lee, MD. ...
Respiratory diseases are a major health burden, and educational inequalities may influence disease prevalence. We aim to evaluate the causal link between educational attainment and respirato...
Some patients with suspected brain metastases (BM) could not tolerate longer scanning examinations according to the standardized MRI protocol.The purpose of this study was to evaluate the cl...
Unwarranted variations in lung cancer care have been well described in both Australia and Aotearoa New Zealand, with shortfalls in hospital-based workforce and infrastructure previously demo...
Exosomes, extracellular vesicles released by cells, hold potential as diagnostic markers for the early detection of lung cancer. Despite their clinical promise, current technologies lack rap...
Two decades of annual low-dose CT screening in the I-ELCAP cohort reveal a sustained 80% lung cancer-specific survival rate, updating the cure rate....
The transition to neoadjuvant therapy in resectable NSCLC is safe and feasible, with comparable complication rates to upfront surgery....
The IASCL grading system predicts outcomes in resected lung adenocarcinomas, with grade 3 tumors showing aggressiveness and benefiting from adjuvant chemotherapy....
To investigate the effects of photodynamic therapy (PDT) mediated by hematoporphyrin derivatives (HPD) on the proliferation of small cell lung cancer H446 cells and bronchial epithelial BEAS...
To elucidate the dosimetric errors caused by a model-based algorithm in lung stereotactic body radiation therapy (SBRT) with Helical TomoTherapy (HT) using Monte Carlo (MC)-based dose verifi...
Cuproptosis-related genes (CRGs) are associated with lung adenocarcinoma. However, the links between CRGs and non-small-cell lung cancer (NSCLC) are not clear. In this study, we aimed to dev...
Astragaloside IV (AS-IV) has been shown to have a curative effect on non-small cell lung cancer (NSCLC). This study aimed to elucidate the role of AS-IV in NSCLC cell anlotinib resistance (A...
Intraoperative frozen section pathology (FS) is widely used to guide surgical strategies while the accuracy is relatively low. Underestimating the pathological condition may result in inadeq...
Surgical resection is the most effective therapeutic option for the cure in early stage resectable non-small-cell lung cancer (NSCLC). However, despite complete resection, up to 70% of patie...
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquir...
2023 NACLC Opening Keynote Speaker Marjory Charlot, MD, MPH, MSc, presented “Equities and Disparities,” focusing on disparities in the management of NSCLC....
Spread through air space (STAS) is a novel invasive pattern of lung adenocarcinoma (LUAD), and preoperative knowledge of STAS status is helpful in choosing an appropriate surgical approach.T...
Lung cancer with the highest incidence and mortality in the world. Immune checkpoint inhibitors (ICIs), can bring long-term survival benefits to patients, but also can bring immune-related a...
The rate of new lung cancer cases has decreased, and survival has improved over the past 5 years, according to the State of Lung Cancer 2023 report published by the American Lung Association...
Researchers described a new familial lung cancer caused by an inherited mutation in EGFR in a study published in the Journal of Clinical Oncology. Geoffrey R. Oxnard, MD, and colleagues enro...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.